SCHEMBL14545893

SCHEMBL14545893

Bc1cnn2c(NCCNC(=O)CN3C(=O)c4ccccc4C3=O)cc(-c3ccccc3Cl)nc12

nearest known ligand 0.46

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
▸ CDK2 P24941 4/20 0.46
▸ GSK3B P49841 4/20 0.44
▸ SMN1; SMN2 Q16637 3/20 0.43
▸ MAPT P10636 1/20 0.40
▸ LMNA P02545 3/20 0.39
▸ PKM P14618 1/20 0.39
▸ KMT2A Q03164 3/20 0.38
▸ MEN1 O00255 2/20 0.38
▸ ALDH1A1 P00352 1/20 0.38
▸ POLB P06746 1/20 0.38
▸ NR4A1 P22736 1/20 0.38
▸ ESR2 Q92731 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13120270 0.89 CDK2 (0.59) CDK2GSK3BSMN1; SMN2LMNAPKM
SCHEMBL13288740 0.85 GSK3B (0.46) CDK2GSK3BLMNAALDH1A1POLB
SCHEMBL13288970 0.85 CDK2 (0.45) CDK2GSK3B
SCHEMBL13289269 0.85 GSK3B (0.46) CDK2GSK3BLMNAKMT2AMEN1
SCHEMBL13288875 0.85 GSK3B (0.46) CDK2GSK3BKMT2AMEN1ALDH1A1
SCHEMBL14545832 0.84 CDK2 (0.48) CDK2GSK3BSMN1; SMN2MAPTLMNA
SCHEMBL13120060 0.84 CDK2 (0.58) CDK2GSK3BSMN1; SMN2
SCHEMBL13289308 0.83 CDK2 (0.53) CDK2GSK3BSMN1; SMN2MAPTKMT2A
SCHEMBL13288867 0.83 CDK2 (0.47) CDK2GSK3B
SCHEMBL12954451 0.83 SMN1; SMN2 (0.38) SMN1; SMN2LMNAPKMKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007044449-A2 NOVEL PYRAZOLOPYRIMIDINES AS CYCLIN DEPENDENT KINASE INHIBITORS SCHERING CORPORATION (US) 2007-04-19 — — WO disclosed
Send feedback